Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells
Authors:
Open Access
- 22 July 2012
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 488 (7411) , 384-388
Abstract
Virulence factors from two bacteria are used to reprogram intracellular signalling in yeast and immune T cells, illustrating how pathogens can provide a toolkit to engineer cells for biotechnological or therapeutic applications. Effector proteins developed by bacterial pathogens to subvert host systems have potential uses in cell engineering for biotechnological or therapeutic applications. For example, many proteins from pathogens with the type III secretion system interfere with mitogen-activated protein kinase (MAPK) pathways. MAPK pathways are central to many eukaryotic responses, so agents capable of modulating them could have many uses — in biotechnological cells such as yeast, in immune cells engineered for adoptive immunotherapy, or to suppress cell growth associated with cancer, for instance. As a proof of principle, Wendell Lim and colleagues use two bacterial virulence factors, OspF from Shigella flexneri and YopH from Yersinia pestis, to modulate MAPK signalling in yeast and human immune cells. Bacterial pathogens have evolved specific effector proteins that, by interfacing with host kinase signalling pathways, provide a mechanism to evade immune responses during infection1,2. Although these effectors contribute to pathogen virulence, we realized that they might also serve as valuable synthetic biology reagents for engineering cellular behaviour. Here we exploit two effector proteins, the Shigella flexneri OspF protein3 and Yersinia pestis YopH protein4, to rewire kinase-mediated responses systematically both in yeast and mammalian immune cells. Bacterial effector proteins can be directed to inhibit specific mitogen-activated protein kinase pathways selectively in yeast by artificially targeting them to pathway-specific complexes. Moreover, we show that unique properties of the effectors generate new pathway behaviours: OspF, which irreversibly inactivates mitogen-activated protein kinases4, was used to construct a synthetic feedback circuit that shows novel frequency-dependent input filtering. Finally, we show that effectors can be used in T cells, either as feedback modulators to tune the T-cell response amplitude precisely, or as an inducible pause switch that can temporarily disable T-cell activation. These studies demonstrate how pathogens could provide a rich toolkit of parts to engineer cells for therapeutic or biotechnological applications.Keywords
This publication has 32 references indexed in Scilit:
- Synthetic biology: applications come of ageNature Reviews Genetics, 2010
- Rapid Diversification of Cell Signaling Phenotypes by Modular Domain RecombinationScience, 2010
- Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical TrialMolecular Therapy, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Tipping the balance by manipulating post-translational modificationsCurrent Opinion in Microbiology, 2010
- Engineering lymphocyte subsets: tools, trials and tribulationsNature Reviews Immunology, 2009
- A Systems-Level Analysis of Perfect Adaptation in Yeast OsmoregulationCell, 2009
- Frequency-modulated nuclear localization bursts coordinate gene regulationNature, 2008
- Signal processing by the HOG MAP kinase pathwayProceedings of the National Academy of Sciences, 2008
- A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferProceedings of the National Academy of Sciences, 2008